[go: up one dir, main page]

CA2243316A1 - Metal complexes that contain perfluoroalkyl, process for their production and their use in nmr diagnosis - Google Patents

Metal complexes that contain perfluoroalkyl, process for their production and their use in nmr diagnosis

Info

Publication number
CA2243316A1
CA2243316A1 CA002243316A CA2243316A CA2243316A1 CA 2243316 A1 CA2243316 A1 CA 2243316A1 CA 002243316 A CA002243316 A CA 002243316A CA 2243316 A CA2243316 A CA 2243316A CA 2243316 A1 CA2243316 A1 CA 2243316A1
Authority
CA
Canada
Prior art keywords
production
metal complexes
nmr diagnosis
contain perfluoroalkyl
perfluoroalkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002243316A
Other languages
French (fr)
Other versions
CA2243316C (en
Inventor
Johannes Platzek
Ulrich Niedballa
Bernd Raduchel
Wolfgang Schlecker
Hanns-Joachim Weinmann
Thomas Frenzel
Bernd Misselwitz
Wolfgang Ebert
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19603033A external-priority patent/DE19603033A1/en
Application filed by Individual filed Critical Individual
Publication of CA2243316A1 publication Critical patent/CA2243316A1/en
Application granted granted Critical
Publication of CA2243316C publication Critical patent/CA2243316C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/22—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with hetero atoms directly attached to ring nitrogen atoms
    • C07D295/26—Sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/0002—General or multifunctional contrast agents, e.g. chelated agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/76—Metal complexes of amino carboxylic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C237/10—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atom of at least one of the carboxamide groups bound to an acyclic carbon atom of a hydrocarbon radical substituted by nitrogen atoms not being part of nitro or nitroso groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Toxicology (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Rheumatology (AREA)
  • Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Diabetes (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

The invention concerns new monomer perfluoroalkyl-substituted metal complexes, a process for their production, and their use in diagnostics and therapy. The compounds according to the invention to the invention are particularly suited for use as in vivo contrast agents in nuclear spin resonance tomography (MRT). They can be preferably used as blood pool agents and contrast agents for lymphography.
CA002243316A 1996-01-19 1997-01-16 Metal complexes that contain perfluoroalkyl, process for their production and their use in nmr diagnosis Expired - Fee Related CA2243316C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19603033A DE19603033A1 (en) 1996-01-19 1996-01-19 Perfluoroalkyl-containing metal complexes, processes for their preparation and their use in NMR diagnostics
DE19603033.1 1996-01-19
PCT/EP1997/000209 WO1997026017A2 (en) 1996-01-19 1997-01-16 Perfluoroalkyl-containing metal complexes and their use in nmr diagnostics

Publications (2)

Publication Number Publication Date
CA2243316A1 true CA2243316A1 (en) 1997-07-24
CA2243316C CA2243316C (en) 2006-09-26

Family

ID=37057084

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002243316A Expired - Fee Related CA2243316C (en) 1996-01-19 1997-01-16 Metal complexes that contain perfluoroalkyl, process for their production and their use in nmr diagnosis

Country Status (1)

Country Link
CA (1) CA2243316C (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6676928B2 (en) 2000-08-11 2004-01-13 Schering Aktiengesellschaft Perfluoroalkyl-containing complexes with polar radicals, process for their production and their use

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6676928B2 (en) 2000-08-11 2004-01-13 Schering Aktiengesellschaft Perfluoroalkyl-containing complexes with polar radicals, process for their production and their use

Also Published As

Publication number Publication date
CA2243316C (en) 2006-09-26

Similar Documents

Publication Publication Date Title
WO1997026017A3 (en) Perfluoroalkyl-containing metal complexes and their use in nmr diagnostics
Jones Jr et al. Neurological manifestations of infective endocarditis. Review of clinical and therapeutic challenges
ATE99544T1 (en) LIPOSOMAL RADIOLOGICAL CONTRAST AGENT.
EP1011415A4 (en) NON-INVASIVE METHODS FOR DIAGNOSING ALZHEIMER'S DISEASE IN MAN
CA2268324A1 (en) Administrable compositions and methods for magnetic resonance imaging
IL122554A0 (en) Cascade polymer complexes process for their production and pharmaceutical agents containing said complexes
SG46496A1 (en) Tricyclopolyazamacrocyclophosphonic acids complexes and derivatives thereof for use as constrast agents
NO954440L (en) 2 pyridylmethylene polyazamacrocyclophosphonic acids, complexes and derivatives thereof, for use as contrast agents
DE69019584D1 (en) Macrocyclic nitrogen ligands Process for their preparation, their metal complexes, diagnostic and therapeutic agents containing them.
CA2299504A1 (en) Antibodies to oxidation-specific epitopes on lipoprotein and methods for their use in detecting, monitoring and inhibiting the growth of atheroma
HUP9900426A3 (en) Amyloid binding azoderivatives, preparation thereof and use of these compounds for the antemortem diagnosis of alzheimer's disease and in vivo imaging and prevention of amyloid deposition
CA2243316A1 (en) Metal complexes that contain perfluoroalkyl, process for their production and their use in nmr diagnosis
FI965094L (en) 2,4,6-triiodo-5-substituted aminoisophthalate esters useful as contrast agents in medical diagnostic imaging
CA2294502A1 (en) Use of intravenous contrast media for projection mammography
DE3443252A1 (en) Dextran-magnetite complexes for NMR diagnosis
EP0638815A3 (en) Method of nuclear spin tomography imaging for creating RARE-images with additional preparation of the magnetization for contrast variation.
WO1999002193A3 (en) Triiodine aromates containing perfluoroalkyl groups, method for the production and use thereof as contrast agents
ZA949604B (en) Haloaryl-substituted metal complexes pharmaceutical agents containing these complexes, their use in diagnosis, as well as process for the production of the complexes and agents
Conlon et al. A study of the corpus callosum in epileptic psychosis using magnetic resonance imaging.
IL96631A0 (en) Magnetic resonance imaging apparatus with artefact reduction
GR3007136T3 (en)
AU8436791A (en) Use of radioactive metal ion complexes with all-cis-1,3,5-triamino-2,4,6-cyclohexantriol and their derivates for x-ray diagnosis and in tumor therapy as well asfor producing x-ray diagnostic and tumor therapy agents
Damji Pulsatile flow artifacts in 2DFT NMR imaging
李卫平 et al. STUDY OF THE EXTERNAL COUNTERPULSATION (ECP) THERAPY FOR SENILE DEMENTIA OF THE ALZHEIMER'S TYPE (SDAT)
Greenwald The coverage that travels.

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed